Cargando…
8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist
cADPR (cyclic ADP-ribose) is a universal Ca(2+) mobilizing second messenger. In T-cells cADPR is involved in sustained Ca(2+) release and also in Ca(2+) entry. Potential mechanisms for the latter include either capacitative Ca(2+) entry, secondary to store depletion by cADPR, or direct activation of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782309/ https://www.ncbi.nlm.nih.gov/pubmed/19492987 http://dx.doi.org/10.1042/BJ20082308 |
_version_ | 1782174635992809472 |
---|---|
author | Kirchberger, Tanja Moreau, Christelle Wagner, Gerd K. Fliegert, Ralf Siebrands, Cornelia C. Nebel, Merle Schmid, Frederike Harneit, Angelika Odoardi, Francesca Flügel, Alexander Potter, Barry V. L. Guse, Andreas H. |
author_facet | Kirchberger, Tanja Moreau, Christelle Wagner, Gerd K. Fliegert, Ralf Siebrands, Cornelia C. Nebel, Merle Schmid, Frederike Harneit, Angelika Odoardi, Francesca Flügel, Alexander Potter, Barry V. L. Guse, Andreas H. |
author_sort | Kirchberger, Tanja |
collection | PubMed |
description | cADPR (cyclic ADP-ribose) is a universal Ca(2+) mobilizing second messenger. In T-cells cADPR is involved in sustained Ca(2+) release and also in Ca(2+) entry. Potential mechanisms for the latter include either capacitative Ca(2+) entry, secondary to store depletion by cADPR, or direct activation of the non-selective cation channel TRPM2 (transient receptor potential cation channel, subfamily melastatin, member 2). Here we characterize the molecular target of the newly-described membrane-permeant cADPR agonist 8-Br-N(1)-cIDPR (8-bromo-cyclic IDP-ribose). 8-Br-N(1)-cIDPR evoked Ca(2+) signalling in the human T-lymphoma cell line Jurkat and in primary rat T-lymphocytes. Ca(2+) signalling induced by 8-Br-N(1)-cIDPR consisted of Ca(2+) release and Ca(2+) entry. Whereas Ca(2+) release was sensitive to both the RyR (ryanodine receptor) blocker RuRed (Ruthenium Red) and the cADPR antagonist 8-Br-cADPR (8-bromo-cyclic ADP-ribose), Ca(2+) entry was inhibited by the Ca(2+) entry blockers Gd(3+) (gadolinium ion) and SKF-96365, as well as by 8-Br-cADPR. To unravel a potential role for TRPM2 in sustained Ca(2+) entry evoked by 8-Br-N(1)-cIDPR, TRPM2 was overexpressed in HEK (human embryonic kidney)-293 cells. However, though activation by H(2)O(2) was enhanced dramatically in those cells, Ca(2+) signalling induced by 8-Br-N(1)-cIDPR was almost unaffected. Similarly, direct analysis of TRPM2 currents did not reveal activation or co-activation of TRPM2 by 8-Br-N(1)-cIDPR. In summary, the sensitivity to the Ca(2+) entry blockers Gd(3+) and SKF-96365 is in favour of the concept of capacitative Ca(2+) entry, secondary to store depletion by 8-Br-N(1)-cIDPR. Taken together, 8-Br-N(1)-cIDPR appears to be the first cADPR agonist affecting Ca(2+) release and secondary Ca(2+) entry, but without effect on TRPM2. |
format | Text |
id | pubmed-2782309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-27823092009-12-03 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist Kirchberger, Tanja Moreau, Christelle Wagner, Gerd K. Fliegert, Ralf Siebrands, Cornelia C. Nebel, Merle Schmid, Frederike Harneit, Angelika Odoardi, Francesca Flügel, Alexander Potter, Barry V. L. Guse, Andreas H. Biochem J Research Article cADPR (cyclic ADP-ribose) is a universal Ca(2+) mobilizing second messenger. In T-cells cADPR is involved in sustained Ca(2+) release and also in Ca(2+) entry. Potential mechanisms for the latter include either capacitative Ca(2+) entry, secondary to store depletion by cADPR, or direct activation of the non-selective cation channel TRPM2 (transient receptor potential cation channel, subfamily melastatin, member 2). Here we characterize the molecular target of the newly-described membrane-permeant cADPR agonist 8-Br-N(1)-cIDPR (8-bromo-cyclic IDP-ribose). 8-Br-N(1)-cIDPR evoked Ca(2+) signalling in the human T-lymphoma cell line Jurkat and in primary rat T-lymphocytes. Ca(2+) signalling induced by 8-Br-N(1)-cIDPR consisted of Ca(2+) release and Ca(2+) entry. Whereas Ca(2+) release was sensitive to both the RyR (ryanodine receptor) blocker RuRed (Ruthenium Red) and the cADPR antagonist 8-Br-cADPR (8-bromo-cyclic ADP-ribose), Ca(2+) entry was inhibited by the Ca(2+) entry blockers Gd(3+) (gadolinium ion) and SKF-96365, as well as by 8-Br-cADPR. To unravel a potential role for TRPM2 in sustained Ca(2+) entry evoked by 8-Br-N(1)-cIDPR, TRPM2 was overexpressed in HEK (human embryonic kidney)-293 cells. However, though activation by H(2)O(2) was enhanced dramatically in those cells, Ca(2+) signalling induced by 8-Br-N(1)-cIDPR was almost unaffected. Similarly, direct analysis of TRPM2 currents did not reveal activation or co-activation of TRPM2 by 8-Br-N(1)-cIDPR. In summary, the sensitivity to the Ca(2+) entry blockers Gd(3+) and SKF-96365 is in favour of the concept of capacitative Ca(2+) entry, secondary to store depletion by 8-Br-N(1)-cIDPR. Taken together, 8-Br-N(1)-cIDPR appears to be the first cADPR agonist affecting Ca(2+) release and secondary Ca(2+) entry, but without effect on TRPM2. Portland Press Ltd. 2009-07-29 2009-08-15 /pmc/articles/PMC2782309/ /pubmed/19492987 http://dx.doi.org/10.1042/BJ20082308 Text en © 2009 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by-nc/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kirchberger, Tanja Moreau, Christelle Wagner, Gerd K. Fliegert, Ralf Siebrands, Cornelia C. Nebel, Merle Schmid, Frederike Harneit, Angelika Odoardi, Francesca Flügel, Alexander Potter, Barry V. L. Guse, Andreas H. 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist |
title | 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist |
title_full | 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist |
title_fullStr | 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist |
title_full_unstemmed | 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist |
title_short | 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist |
title_sort | 8-bromo-cyclic inosine diphosphoribose: towards a selective cyclic adp-ribose agonist |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782309/ https://www.ncbi.nlm.nih.gov/pubmed/19492987 http://dx.doi.org/10.1042/BJ20082308 |
work_keys_str_mv | AT kirchbergertanja 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT moreauchristelle 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT wagnergerdk 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT fliegertralf 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT siebrandscorneliac 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT nebelmerle 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT schmidfrederike 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT harneitangelika 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT odoardifrancesca 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT flugelalexander 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT potterbarryvl 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist AT guseandreash 8bromocyclicinosinediphosphoribosetowardsaselectivecyclicadpriboseagonist |